Standout Papers

Trastuzumab deruxtecan in patients with central nervous system involvement from HER2-positive breast cancer: The DEBBRAH ... 2022 2026 2023 2024152
  1. Trastuzumab deruxtecan in patients with central nervous system involvement from HER2-positive breast cancer: The DEBBRAH trial (2022)
    José Manuel Pérez-García, Marta Vaz Batista et al. Neuro-Oncology

Immediate Impact

2 from Science/Nature 71 standout
Sub-graph 1 of 22

Citing Papers

Multiplexed 3D atlas of state transitions and immune interaction in colorectal cancer
2023 Standout
Probiotic-guided CAR-T cells for solid tumor targeting
2023 StandoutScience
2 intermediate papers

Works of Sofía Braga being referenced

Randomized Phase II Study of the Anti–Epidermal Growth Factor Receptor Monoclonal Antibody Cetuximab With Cisplatin Versus Cisplatin Alone in Patients With Metastatic Triple-Negative Breast Cancer
2013

Author Peers

Author Last Decade Papers Cites
Sofía Braga 896 408 349 417 49 1.4k
Gro Wiedswang 1060 332 754 369 38 1.7k
Susan Fineberg 620 207 486 444 59 1.6k
Roberta Maltoni 690 287 358 328 82 1.2k
Véronique D’Hondt 763 329 234 287 81 1.3k
Giovanna Masci 768 366 510 461 74 1.6k
Theresa L. Werner 762 242 264 489 96 1.7k
Matthew Maurer 808 209 227 609 53 1.3k
J F Holland 651 239 189 419 47 1.3k
Konstantinos Tryfonidis 1082 391 744 310 53 1.7k
Antje Lebrecht 591 144 296 396 56 1.3k

All Works

Loading papers...

Rankless by CCL
2026